Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.

Abstract

The beta-lactamases from 403 Moraxella (Branhamella) catarrhalis clinical isolates obtained during 1994-1995 and 1997-1998 U.S. multicenter surveillance studies were characterized by isoelectric focusing. The overall prevalences of the BRO-1 and BRO-2 enzymes among beta-lactamase-positive isolates were estimated to be 97.5 and 2.5%, respectively. The… (More)

Topics

Cite this paper

@article{Richter2000MolecularCO, title={Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.}, author={Sandra S. Richter and Patricia L. Winokur and Angela B. Brueggemann and Holly K Huynh and Paul R. Rhomberg and E M Wingert and Gary V. Doern}, journal={Antimicrobial agents and chemotherapy}, year={2000}, volume={44 2}, pages={444-6} }